These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 8156960

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Vigabatrin: rational treatment for chronic epilepsy.
    Ring HA, Heller AJ, Farr IN, Reynolds EH.
    J Neurol Neurosurg Psychiatry; 1990 Dec; 53(12):1051-5. PubMed ID: 2292696
    [Abstract] [Full Text] [Related]

  • 4. Antiepileptic drugs in development: prospects for the near future.
    Leppik IE.
    Epilepsia; 1994 Dec; 35 Suppl 4():S29-40. PubMed ID: 8174517
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Vigabatrin and lamotrigin: experiences with 2 new anticonvulsants in the Swiss epilepsy clinic].
    Vogt H, Krämer G.
    Schweiz Med Wochenschr; 1995 Jan 28; 125(4):125-32. PubMed ID: 7878401
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rationalized polytherapy for epilepsy.
    Goldsmith P, de Bittencourt PR.
    Acta Neurol Scand Suppl; 1995 Jan 28; 162():35-9. PubMed ID: 7495188
    [Abstract] [Full Text] [Related]

  • 11. Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy.
    Dodrill CB, Arnett JL, Sommerville KW, Sussman NM.
    Epilepsia; 1995 Feb 28; 36(2):164-73. PubMed ID: 7821274
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of vigabatrin on sedation and cognitive function in patients with refractory epilepsy.
    Gillham RA, Blacklaw J, McKee PJ, Brodie MJ.
    J Neurol Neurosurg Psychiatry; 1993 Dec 28; 56(12):1271-5. PubMed ID: 8270925
    [Abstract] [Full Text] [Related]

  • 14. Pharmacology of vigabatrin.
    Sabers A, Gram L.
    Pharmacol Toxicol; 1992 Apr 28; 70(4):237-43. PubMed ID: 1608908
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of vigabatrin in the long-term treatment of refractory epilepsy.
    Remy C, Beaumont D.
    Br J Clin Pharmacol; 1989 Apr 28; 27 Suppl 1(Suppl 1):125S-129S. PubMed ID: 2757903
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vigabatrin in the treatment of epilepsy in children.
    Livingston JH, Beaumont D, Arzimanoglou A, Aicardi J.
    Br J Clin Pharmacol; 1989 Apr 28; 27 Suppl 1(Suppl 1):109S-112S. PubMed ID: 2757901
    [Abstract] [Full Text] [Related]

  • 18. Effects of vigabatrin on cognitive function and mood when used as add-on therapy in patients with intractable epilepsy.
    McGuire AM, Duncan JS, Trimble MR.
    Epilepsia; 1992 Apr 28; 33(1):128-34. PubMed ID: 1733746
    [Abstract] [Full Text] [Related]

  • 19. Vigabatrin for refractory complex partial seizures: multicenter single-blind study with long-term follow-up.
    Browne TR, Mattson RH, Penry JK, Smith DB, Treiman DM, Wilder BJ, Ben-Menachem E, Napoliello MJ, Sherry KM, Szabo GK.
    Neurology; 1987 Feb 28; 37(2):184-9. PubMed ID: 3808298
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.